BCL2 and neoplasm: Immunohistochemical stain revealed that tumor cells were diffusely positive for CD20, CD79a, bcl-2, and negative for CD3, CD5, CD10, cyclin D1 and bcl-6, which excludes the possibility of low grade B-cell lymphoma other than EMZL.